http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009133315-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 2008-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009133315-A |
| titleOfInvention | PROGESTERON FOR TREATMENT OR PREVENTION OF SPONTANEOUS PREMATURE BIRTH |
| abstract | 1. A method of treating or preventing the onset of preterm labor and subsequent preterm labor in a pregnant woman with a shortened or smoothed cervix, which comprises administering to the indicated woman a drug comprising progesterone in an amount sufficient to minimize shortening or thinning of the cervix. ! 2. A method of reducing neonatal complications and mortality of a premature baby, which comprises administering to a pregnant woman with a shortened or smoothed cervix uterus a drug comprising progesterone in an amount sufficient to minimize or delay further shortening or thinning of the cervix or to prolong the period of pregnancy. ! 3. The method according to claim 1 or 2, in which the drug is in the form of a vaginal gel, vaginal suppository, vaginal cream or in the form of a solid vaginal dosage form. ! 4. The method according to claim 1 or 2, in which the drug is administered intramuscularly, oral, rectal, subcutaneous, vaginal, intradermal, local, intranasal, intraperitoneal, intraarticular, intraventricular, intrathecal, intravaginal or intravenous. ! 5. The method according to claim 1 or 2, in which progesterone is a natural progesterone or metabolite of progesterone. ! 6. The method according to claim 1 or 2, in which progesterone comprises synthetic progesterone selected from caproate 17-alpha-hydroxy-progesterone, medroxyprogesterone acetate, norethindrone, norethindrone acetate, norethindrone enanthate, desogestrel, levonorgestrel, linestrenol, ethinodiol diacetone |
| priorityDate | 2007-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.